Posts Tagged ‘clinical trials’

  Several months ago I posted Why Don’t I See Ads For Clinical Trials?, a piece in which I questioned just that. In a society where healthcare is always front and center, how is it that most of us are still unaware of our options when it comes to participating in clinical research? 

  Now that November is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in October – they’re ranked in order of popularity, with number one being the most viewed piece. 

  Academic research organizations (AROs) and academic medical centers (AMCs) are university-based institutions that conduct scientific research and play a vital role in the development of new drugs and medical devices. Historically, the majority of the research performed by AROs and AMCs has been funded by government divisions like the National Institutes of Health (NIH). […]

  Now that October is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in September – they’re ranked in order of popularity, with number one being the most viewed piece. 

  Check this out. Roche just developed a mobile app, which is currently being evaluated in a Phase I trial, that can help assess the severity of one’s Parkinson’s disease (PD). Here’s how it works: Patients are provided with pre-configured smartphones and, over time, are guided through a series of tests to collect data points. […]

  Life sciences organizations are in the business of developing drugs and medical devices. Hitting key milestones and moving trials to the next phase has always been a priority. Throughout this entire process, the collection and analysis of clinical and safety data is essential in taking products to subsequent stages, and ultimately getting them approved […]

  It seems like every other day we’re reading about pharmaceutical companies developing mobile apps, or at the very least, investing in companies that develop them. And that’s for good reason: They work. They help researchers learn about disorders. They help educate patients on their conditions and provide treatment recommendations. They help with patient adherence. […]

  Keith Lovell just left Shazam, the company behind the popular app that magically tells you the artist performing the song playing in the background at Cheesecake Factory. With almost a decade as the company’s CFO, he chose to join TrialReach, a technology company focused on helping patients find the clinical trials they’re eligible for, based on […]

  Let’s face it: Keeping clinical trials on schedule is not easy to do. Whether a sponsor runs into issues with quality, timeline, personnel, or myriad other things with an outsourced partner, it’s crucial to address the problems as soon as they’re identified. There are a few routes a sponsor can take when a study […]

  I’m sitting at my desk thinking to myself: Why don’t I see many ads trying to recruit patients for clinical trials? “Many” is actually an overstatement. I rarely see them. Anywhere. And that’s a problem. I’m fairly healthy, but I have some issues. I’m slowing balding. I suffer from heartburn. Sometimes, I have debilitating […]

  One question we often get relates to disabling Oracle Clinical (OC) and Remote Data Capture (RDC) accounts. What happens to the OC/RDC accounts of users who separate from a company or roll off of a clinical trial? The answer is relatively simple, though not necessarily obvious, because the only way to tell if an […]

  Over the past few months, the life sciences practice has produced several free resources related to the 21 CFR Part 11 regulation that governs electronic records and electronic signatures. To make it easy for our industry colleagues to find those resources, we decided to create a single blog post that links to all of […]